Dry Eye Syndromes: all 1,325 studies

Page 3 of 14. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.CompletedNCT06375499Not applicableResults posted
• A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive AccuracyCompletedNCT06346340Phase 4Results posted
• A Study Evaluating the Safety of the Nasal PumpTerminatedNCT06329687Phase 4Results posted
• A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With CyclosporineCompletedNCT06329661Phase 4Results posted
• A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye DiseaseCompletedNCT06309953Phase 4Results posted
• A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.CompletedNCT06244316Phase 2Results posted
• Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant BalanceCompletedNCT06219577Phase 4Results posted
• Eyelid Androgen Treatment in Dry EyeCompletedNCT06154200Phase 2Results posted
• Mechanisms of Light-based Therapies for Dry Eye DiseaseCompletedNCT06004895Not applicableResults posted
• A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult ParticipantsTerminatedNCT05992922Phase 2Results posted
• Performance and Safety of T2769 in DEDCompletedNCT05965778Not applicableResults posted
• Systane® Complete Preservative Free Lubricant Eye DropsCompletedNCT05932225Not applicableResults posted
• Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.CompletedNCT05931861Not applicableResults posted
• Phase 4 Study Evaluating the Safety of the Nasal Guide With TyrvayaCompletedNCT05918406Phase 4Results posted
• Systane® Ultra Preservative Free Lubricant Eye DropsCompletedNCT05902364Not applicableResults posted
• A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult ParticipantsCompletedNCT05878067Phase 3Results posted
• Effects of NOV03 on the Tear FilmCompletedNCT05723770Phase 4Results posted
• Artificial Tears, Tear Lipids and Tear Film DynamicsCompletedNCT05705518Phase 4Results posted
• Nasal Spray Study in Sjogren's Dry Eye DiseaseCompletedNCT05700422Phase 4Results posted
• Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing PatientsCompletedNCT05661851Phase 2Results posted
• Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye DiseaseCompletedNCT05586152Phase 1/2Results posted
• Pilot Study of TENS for Ocular PainCompletedNCT05531643Not applicableResults posted
• Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens WearersCompletedNCT05505292Phase 4Results posted
• A Long-Term Safety Study Evaluating the Safety and Systemic Exposure of AR-15512CompletedNCT05493111Phase 3Results posted
• Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseaseCompletedNCT05486728Phase 2Results posted
• Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)CompletedNCT05467293Phase 2Results posted
• A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye DiseaseCompletedNCT05424549Phase 2Results posted
• A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry EyeCompletedNCT05411367Phase 3Results posted
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye DiseaseCompletedNCT05403827Phase 3Results posted
• Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT05370495Phase 1/2Results posted
• Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)CompletedNCT05360966Phase 3Results posted
• Safety Study of Tivanisiran to Treat Dry EyeCompletedNCT05310422Phase 3Results posted
• Effects of Carboxymethylcellulose Artificial Tears on the Eye MicrobiomeCompletedNCT05292755Phase 4Results posted
• Study Evaluating the Safety and Efficacy of AR-15512CompletedNCT05285644Phase 3Results posted
• Study of ST-100 as Treatment for Dry Eye DiseaseCompletedNCT05241470Phase 2Results posted
• Dailies Total 1 Sphere Contact LensesCompletedNCT05239494Not applicableResults posted
• Total30 Sphere Contact LensesCompletedNCT05183022Not applicableResults posted
• to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland DysfunctionCompletedNCT05162261Not applicableResults posted
• Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye DiseaseCompletedNCT05136170Phase 3Results posted
• Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)CompletedNCT05133180Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry EyeCompletedNCT05109702Phase 3Results posted
• An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease ChamberCompletedNCT05102409Phase 2Results posted
• Ocular Effects of Scleral Lens Wear on Dry Eye PatientsCompletedNCT05079321Not applicableResults posted
• The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseCompletedNCT05062330Phase 3Results posted
• A Clinical Trial to Assess Subjects With Dry Eye Disease.CompletedNCT04971031Phase 2Results posted
• Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland DisfunctionCompletedNCT04889950Not applicableResults posted
• Digital Device Users Who Are Treated With Systane Hydration PFCompletedNCT04837807Phase 4Results posted
• Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)CompletedNCT04795752Not applicableResults posted
• To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye DiseaseCompletedNCT04747977Phase 2Results posted
• A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT04735393Phase 3Results posted
• Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye DiseaseCompletedNCT04734210Phase 2Results posted
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye DiseaseCompletedNCT04734197Phase 2Results posted
• Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.CompletedNCT04704531Phase 2Results posted
• Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.CompletedNCT04702776Phase 4Results posted
• The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseCompletedNCT04674358Phase 2/3Results posted
• Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE FittingCompletedNCT04649177Not applicableResults posted
• Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)CompletedNCT04567329Phase 3Results posted
• Study of VVN001 Ophthalmic Solution in Dry Eye DiseaseCompletedNCT04556838Phase 2Results posted
• Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or LotemaxCompletedNCT04555694Phase 4Results posted
• Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)CompletedNCT04535947Phase 2Results posted
• CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004CompletedNCT04523142Phase 3Results posted
• ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)CompletedNCT04523129Phase 3Results posted
• Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry EyeTerminatedNCT04498468Phase 4Results posted
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedNCT04498182Phase 2Results posted
• Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With KeratoconusCompletedNCT04418999Early Phase 1Results posted
• Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye DiseaseCompletedNCT04393441Phase 3Results posted
• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye DiseaseCompletedNCT04391894Phase 2Results posted
• Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.CompletedNCT04362670Phase 1/2Results posted
• Effect of Cequa™ in Subjects With Dry Eye DiseaseCompletedNCT04357795Phase 4Results posted
• Safety and Efficacy of BRM421 for Dry Eye Syndrome TreatmentCompletedNCT04343287Phase 2/3Results posted
• The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens WearersCompletedNCT04297618Phase 4Results posted
• An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear LakeCompletedNCT04280653Not applicableResults posted
• Meibomian Gland Dysfunction TreatmentCompletedNCT04229888Not applicableResults posted
• Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye SyndromeCompletedNCT04206020Phase 3Results posted
• Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT04201574Phase 1/2Results posted
• Effect of Intraoperative Dexamethasone on Post-op Dry EyeCompletedNCT04184999Phase 4Results posted
• Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye DiseaseCompletedNCT04181593Phase 3Results posted
• Effects of Supplementation With PUFAs and Antioxidants for Contact Lens DiscomfortTerminatedNCT04163328Phase 4Results posted
• Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye DiseaseTerminatedNCT04159935Phase 4Results posted
• Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye SyndromeCompletedNCT04147650Phase 2/3Results posted
• 3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)CompletedNCT04144413Phase 3Results posted
• Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)CompletedNCT04140227Phase 3Results posted
• Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)CompletedNCT04139798Phase 3Results posted
• Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye DiseaseCompletedNCT04139122Phase 1/2Results posted
• Clinical Trial to Compare the Safety and Efficacy of Nanodrop®CompletedNCT04111965Phase 1/2Results posted
• Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens TypeCompletedNCT04105842Not applicableResults posted
• A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry EyeCompletedNCT04092907Phase 2Results posted
• Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry EyeCompletedNCT04091581Phase 4Results posted
• A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye DiseaseCompletedNCT04084483Phase 2Results posted
• Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic SolutionCompletedNCT04081610Phase 1Results posted
• Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEdayCompletedNCT04037969Not applicableResults posted
• Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye DiseaseCompletedNCT04036292Phase 3Results posted
• A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye DiseaseCompletedNCT04030962Phase 1/2Results posted
• Management of Signs and Symptoms Associated With Dry Eye DiseaseTerminatedNCT04015219Not applicableResults posted
• IVIG-eye Drops Treatment for Dry Eye DiseaseCompletedNCT03992482Phase 1/2Results posted
• A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry EyeCompletedNCT03982368Phase 2Results posted
• Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter StudyCompletedNCT03956225Not applicableResults posted
• Azithromycin for Meibomian Gland DiseaseTerminatedNCT03953118Phase 4Results posted
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3CompletedNCT03937882Phase 3Results posted
• Tavilermide Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT03925727Phase 3Results posted

← Dry Eye Syndromes overview